period. We show that this material-surface driven sGC reaction can be successfully applied to not only splenic B cells but also B cells isolated from more therapeutically relevant sources such as peripheral blood mononuclear cells (PBMCs), thus making our current work an exciting prospect in the new era of personalized medicine and custom-immunotherapy.
Introduction
As a critical arm of adaptive immunity, B cells provide humoral immunity by producing antibodies towards various pathogens. In particular, the generation of memory B cells and longlived plasma cells (LLPCs) is critical to immune memory and protection from recurring infection.
Memory B cells recognize and are rapidly activated by recurring antigens to secrete antigenspecific high-affinity antibodies. LLPCs produce and maintain the protective level of these antibodies in the serum. We hypothesized that we can recapitulate the GC reaction ex vivo by effectively synthesizing the critical signaling events provided by T FH cells and FDCs (Fig. 1a) in the presence of an antigen. Traditionally, in-vitro B cell activation has been achieved by engagement of CD40 molecules on B cell membrane using anti-CD40 antibodies 1 , recombinant (CD40L) [2] [3] [4] , or coculture with supporting cell lines that have been genetically modified to express CD40L 5, 6 .
Recently, Kitamura and colleagues have developed a fibroblast-based feeder cell line that expresses both CD40L and B-cell activating factor (BAFF), particularly for the purpose of generating ex-vivo GC reactions 7, 8 . It was also reported that culturing these feeder cells in a hydrogel composed of Arg-Gly-Asp(RGD)-presenting extracellular matrix enhanced the cocultured B cell survival and differentiation 910 . Despite these previous efforts, it has not been explored whether a purely synthetic, biomaterials-based design can effectively recapitulate The selective expansion of antigen-specific B cell clones is initiated by the effective antigen presentation by FDC. As these B cell clones proliferate in the GCs, the affinities toward antigenic epitopes are increased by somatic hypermutation (SHM) of immunoglobulin (Ig) antigen receptor genes under a concurrent selection mechanism [11] [12] [13] for high-affinity clones (affinity maturation). There has been little effort to emulate this critical aspect of the GC reaction ex vivo.
If successful, such sGC reaction and ex-vivo generation of high quality and high affinity antigenspecific B cells could provide significant advancement in treating various diseases that require antigen-specific humoral immunity.
Here, we report that GC reactions can be effectively recapitulated ex vivo by purely biomaterials-based artificial T FH and FDCs with polyvalent presentation of ligands or antigens. By testing and comparing various CD40 ligation methods for their capability to induce expansion, class switch recombination, and expression of GC B cell-specific phenotypes, we found that surface-density controlled CD40L presentation by microbeads were the most effective as artificial T FH cells. Additionally, microbead surface-bound or multimeric antigen presentation were successfully employed to create enriched populations of antigen-specific B cells that had undergone class-switched and somatic hypermutation. Importantly, these sGC reactions were applied to not only spleen-isolated B cells but also the B cells isolated from peripheral blood mononuclear cells (PBMCs), a critical aspect for clinical translation. Ex-vivo sGC-generated B cells engrafted to the spleen and the lymph nodes following adoptive transfer, suggesting that these cells can be potentially used in immunotherapy as a novel means to confer antigen-specific humoral immunity. (Fig. 1a) .
As soluble anti-CD40 antibody (Fig. 1b) . For B cells activated by αCD40, cell viability measured on Day 6 was only about 2~5%, thus implying that αCD40 culture induces apoptosis. Flow cytometry was employed to examine class switch recombination (CSR), differentiation into plasma cells, and expression of GC phenotypes (Fig. 1c, d) . A moderate level of CSR from IgM to IgG1 and expression of CD138, the plasma cell marker, was achieved in the culture using αCD40 compared to the minimal CSR and CD138 expression in the culture with CD40L. Conversely, CD40L was superior in induction of GC phenotypes (GL7+ Fas+) to αCD40. Thus in the perspective of GC reaction, αCD40 was more effective in induction of CSR than CD40L, but CD40L was superior to αCD40 in B cell expansion and in differentiation to GClike B cells (Fig. 1e) . Therefore, we could conclude that both natural ligation of CD40 using CD40L and crosslinking of CD40 might be necessary to induce an effective synthetic GC (sGC) reaction.
Microbead-based artificial T FH design presenting polyvalent CD40L with a controlled surface density effectively induced sGC reaction.
In order to induce effective crosslinking of CD40 while leveraging the natural CD40-CD40L ligation, we designed a microbead-based artificial T FH cell using recombinant CD40L tagged with HA peptide and iron oxide microbeads coated with anti-HA antibodies (Fig. 2a) . Using this artificial T FH , sGC reaction was induced in presence of BAFF and IL-4. Splenic B cells quickly formed a complex with these artificial T FH , and grew as an organoid structure mimicking physiological germinal centers within 48 hours (Fig. 2b) . As these sGC structures developed, areas enriched with artificial T FH microbeads (darker under phase contrast optical microscope) often separated from the areas enriched with B cells.
The unique advantage of such a biomaterial-based sGC design is that critical reaction parameters can be quantitatively controlled and tested. Specifically, we investigated how the sGC reaction can be modulated by controlling the dose of CD40L, the surface density of CD40L, and the ratio of B cells to artificial T FH microbeads. sGC reaction conditions using soluble CD40L, with or without the soluble crosslinking antibody, were also tested for direct comparisons. First, the dose of CD40L was optimized by testing a range of densities over several orders of magnitudefrom 0.1 to 100 ng ml -1 per 10 5 cells. Microbeads were coated with CD40L molecules at a maximum density, approximately 2.7 x 10 4 molecules μm -2 . To achieve the maximum dose (100 ng ml -1 for 10 5 cells), approximately 100 microbeads per B cell were needed. We employed two different methods to test lower doses -first by lowering the cell to bead ratio while keeping the maximum CD40L surface density constant, and second by lowering the CD40L surface density while keeping the cell to bead ratio constant (at 1 to100). B cell expansion, measured by live cell count on Day 6 of sGC culture (Fig. 2c) , showed a clear CD40L-dose dependence. Further, the presence of soluble crosslinking antibody for soluble CD40L significantly increased cellular expansions. The expansion of B cells in sGC culture with microbead surface-bound CD40L increased in a dose dependent manner up to 10 ng ml -1 , but decreased at the maximum dose.
This decrease in B cell expansion at the maximum dose is likely due to cytotoxicity from high number of microbeads, which is supported by the fact that better B cell expansion was achieved by lowering [cell:bead] ratio to 1:10 compared to lowering the surface density of CD40L for the same dose of 10 ng ml -1 . Fig. 1, 2) .
Next, using flow cytometry, we investigated CSR and differentiation status of the B cells harvested at Day 6 of each sGC culture. First, the use of microbead-bound CD40L as artificial T FH significantly improved the CSR, compared to the soluble systems ( Fig. 2d-f Second, we also tested the differentiation status of resulting B cells by checking the expression of typical GC B cell markers, GL7+Fas+ and CD38-CD80+ (Fig. 2g, 2h , and Supplementary Fig.1 and 2 ). When we compare the two highest CD40L doses of all the culture conditions, cultures with microbead-based artificial T FH cells induced equivalent (GL7+Fas+) or more (CD38-CD80+) GC B cell populations (>80%) compared to the number generated in culture conditions with soluble CD40L. Altogether, we conclude that effective recapitulation of T FH cell functions was achieved by using controlled surface presentation of CD40L on the microbreads to modulate the quality and strength of CD40-CD40L ligations. The T cell dependent critical aspects of germinal center reaction, i.e. B cell expansion, CSR, and expression of GC B cell phenotypes, were successfully achieved in vitro.
It is noteworthy that this sGC reaction was also successfully applicable to B cells isolated from PBMCs (Supplementary Fig. 3) , and completely transformed the majority of non-class switched naïve B cell populations to IgG1+ GC B cells within 5 days of culture.
IL-4 induced sGC B cells are transcriptionally similar to centrocytes and commit to plasma cell lineage upon incubation in IL-21
We investigated the transcriptional programs involved in the sGC B cell differentiation process by using real-time quantitative PCR (RT-PCR) analysis. First, we tested the expression level of activation induced cytidine deaminase (AICDA or AID), which is known to be highly expressed in GC B cells and is involved in both CSR and SHM. [15] [16] [17] As expected, sGC B cells express high levels of AICDA mRNA within 3 days of culture, compared to naïve follicular B cells as well as antigen-specific natural GC (nGC) B cells isolated 2 weeks after vaccination (Fig. 3a) . BCL6 is known to be a critical transcriptional factor involved in GC reaction, as mice deficient in BCL6 are characterized by lack of GC formation and inability to produce affinity-matured antibodies. 18, 19 However, expression levels of BCL6 mRNA in sGC B cells are lower than total natural GC B cells and even lower than follicular B cells (Fig. 3b) . This data can be explained by the fact that GC B cells are composed of two sub-stages, centroblasts and centrocytes, in early and later stages of GC reactions, respectively. BCL6 is upregulated in rapidly proliferating centroblasts and is involved in transcriptional repression of many genes to suppress the pre-mature activation and apoptosis of early GC B cells. But only a small percentage of centroblasts are further activated by T-cell dependent CD40 signaling, proceeding into centrocytes in which BCL6 expression is downregulated. 20 The release from BCL6 transcriptional repression is required for CSR, SHM, and further differentiation of centrocytes into memory B cells and plasma cells. 21 Therefore, the majority of our sGC B cells seem to be differentiated into centrocyte stage much more quickly than in a natural GC reactions due to the ubiquitous activation with CD40-signaling.
In a separate experiment, we observed that switching the exogenous cytokine from IL-4 to IL-21 on Day 3 of sGC culture CD40L promote differentiation of centrocytes to plasma cells by upregulation of transcriptional factor Blimp-1, 22 we also examined the expression level of PRDM1 gene that encodes Blimp-1.
PRDM1 has been shown to be expressed in a small subset of centrocytes and is critically required for the formation and maintenance of plasma cells. 23, 24 Our sGC B cells at Day 3 under IL-4 already express higher levels of PRDM1 compared to follicular B cells or natural GC B cells (Fig.   3c ). Among the sGC B cells that are maintained under IL-4 for 6 days (sGC_44), only the CD138+ cells express upregulated level of PRDM1. And upon switching IL-4 to IL-21, PRDM1 mRNA level was indeed greatly enhanced both in CD138-and CD138+ populations (Fig. 3c) .
Altogether, our sGC B cells induced under IL-4 seem to be able to undergo AICDAdependent GC reactions such as CSR and SHM, and rapidly differentiate into a centrocyte-like state by suppressing BCL6 activity. Upon switching cytokine environment from IL4-to IL-21,
AICDA is down-regulated and differentiation commitment into plasma cell lineage is greatly enhanced.
Enriched populations of functional antigen-specific B cells were effectively induced by sGC reaction following fluorescence activated cell sorting (FACS)
In order to fully recapitulate the induction of antigen-specific humoral immunity as a result of
physiological GC reactions, we tested the selection of B cell populations containing antigen- (Fig. 4c) . For both sGC_44 and sGC_421 conditions, the FACS enrichment produced a significantly higher number (~14 times for IgM, ~3 times for IgG1) of OVA specific ASCs (Fig. 4d) , which validates the use of FACS enrichment. It is worth noting that the ASCs generated from the sGC reactions are still mostly of IgM isotype. It is similar to the physiological immune responses, where IgM is always the first class of antibody secreted from the initially generated plasmablasts.
Nevertheless, by combination of flow cytometry and ELISPOT, we ultimately confirmed that the antigen-specific enrichment by FACS followed by sGC reaction will be useful for the generation of antigen-specific ASCs. μm -2 . Neither soluble nor bead-bound OVA brought about a significant increase in the size of OVA-specific population, up to 100 ng ml -1 , compared to that without using OVA. However, at the maximum dose tested, 1 μg ml -1 , soluble and bead presentation of OVA yielded 2.4 and 18 times higher OVA-specific populations compared to no-OVA-in-culture conditions, respectively (Fig. 5a) .
By direct comparison, the bead presentation created ~5 times higher fraction (avg. 3.82%) of OVA-specific cells than the soluble presentation (avg. 0.76%) (Fig. 5b) .
We also cultured B cells with hapten 4-hydroxy-3-nitrophenylacetyl (NP)-conjugated BSA in either soluble form or presented on an artificial FDC surface, with either IL-4 treatment for 6 days of culture (sGC_44) or combined treatment of IL-4 for 3 days followed by IL-21 for 3 days (sGC_421). While soluble NP antigen up to 1000 ng/mL did not yield a significant increase in the number of NP-specific ASCs (IgM or IgG1), bead-bound NP antigen at 100 and 1000 ng/mL resulted in an 1.85-and 1.75-fold increase of IgM+ NP specific ASCs, respectively, compared to the negative control (Fig. 5c) . Interestingly, this increase was only observed using sGC_421
conditions for IgM, and was not observed in either sGC_44 or sGC_421 conditions for IgG1. (Fig. 6a) .
To study the antigen-driven effects, we decided to enrich the pOVA specific populations by use of FACS before sGC reactions. As shown above, FACS enrichment gave rise to more than 10% of pOVA specific cells after 6 days of sGC cultures. It was intriguing that high-fluorescence staining populations emerged only from the culture with pOVA-tetramer (Fig. 6a, b) . It is also worth noting that the similar emergence of brightly-staining populations was repeatedly observed in every sGC culture using different CD40-ligation methods, i.e. anti-CD40 antibody, soluble CD40L, and bead-bound CD40L, but only in the presence of tetrameric antigens during the culture.
Next, we employed a next-generation sequencing technology (454 Sequencing, Roche)
to investigate the occurrence of mutations in the heavy chain of resulting BCRs from sGC reactions. For the two pOVA-specific B cell populations harvested from sGC reactions, with or without the tetrameric pOVA during the cultures, we acquired a total of 1,644 sequences, representing 6 different VH gene families and 85 clones with shared CDR3 junctions. For each population, we only analyzed productive, full-length heavy chain sequences. We analyzed the sequences acquired using forward primer (5' VHE) separately from the sequences acquired using reverse primer (3' Cμ). Thus the forward sequencing data represent potentially all isotype classes, while the reverse sequencing data were IgM-specific. Interestingly, when the average number of mutations per sequence were calculated for each dataset, the forward sequencing data from the sGC culture with tetrameric pOVA gave rise to a significantly high number (9.15), compared to the others (forward sequencing data without the antigen (3.68), IgM-specific sequencing data with and without the antigen, 4.10 and 5.54, respectively) (Fig. 6c) . This indicates a potential enhancement in mutations among the isotype-switched B cells in the presence of multimeric antigens. In a further analysis to calculate the ratio of total number of transition mutations (exchange of a purine for a purine or of a pyrimidine for a pyrimidine) to transversion mutations (exchange of a purine for a pyrimidine or vice versa) in each dataset, transitions were much more favored over transversions only in the forward sequencing data acquired from the B cells cultured with tetrameric pOVA (Fig. 6d) , among which transitions of C:G pairs slightly outnumbered those of A:T pairs (Fig. 6e) . These data suggest that the higher number of mutations observed in this dataset is likely due to the somatic hypermutation (SHM) triggered by activation-induced deaminase (AID) 31 .
Adoptively transferred sGC B cells engrafted in the secondary lymphoid organs, maintaining their centrocyte or memory B phenotypes
If the B cells generated from sGC reaction can be adoptively transferred, it could potentially serve as a novel autologous cell therapy regimen for the induction of long-term antigen-specific humoral immunity. In order to test the feasibility of this, we adoptively transferred approximately 1 x 10 7 CFSE-loaded B cells from a 6-day sGC culture into non-irradiated syngeneic mice. The spleen and lymph nodes were harvested 4 days after the adoptive B cell transfer (ABCT). In flow cytometry analyses, both the spleen and the pooled lymph nodes harvested from the mice after ABCT contained higher number of CFSE-positive cells compared to the control mice without the ABCT ( Fig. 7a and b) . And these CD19+CFSE+ double positive donor B cells expressed IgG1, CD80 (B7.1), and Fas, which were not expressed in the majority of CD19+CFSE-recipient mouse B cells (Fig. 7c) . When lymph nodes harvested 4 days after ABCT were examined using immunofluorescence microscopy, the CFSE+ cells were scattered throughout the perifollicular regions, B-cell zone as well as some in the T-cell zone (Fig. 7d) .
In order to track the adoptively transferred sGC B cells for a longer period, we generated sGC B cells expressing genetic marker (CD45.1+) and transferred them into non-lethally irradiated (6.5
Gy) congenic host mice intravenously. After 4 weeks, donor-derived B cells (CD45.1+ CD19+)
were evidently detected both in the spleen and in the lymph nodes (Fig. 7e) . Compared to the low percentage of IgG1+ populations in the recipient B cells, about half of the donor B cells were IgG1+ (Fig. 7e) . However, the distinctive expression levels of GC B cell makers, GL7, CD80, CD38, and Fas, which were maintained in the donor B cells for at least 4 days, have mostly disappeared by 4 weeks after ABCT to be very similar to the expression levels of naïve B cells from the recipient mice (Fig. 7f) . These results suggest that the B cells cultured in sGC conditions can be adoptively transferred in during an autologous cell therapy to successfully engraft in the secondary lymphoid organs within short periods without losing their GC phenotype, and also survive long periods as latent B cells.
Discussion
Previously, engagement of CD40 molecules on B cells using soluble anti-CD40 or CD40L were widely used to activate B cells without comprehensive studies on their potential usage in artificial GC reactions. Here, we found that both of these approaches were only partially effective in 34, 35 , and it is likely that different methods of engagement for CD40 might induce an equal variety of gene expression profiles. In vivo, CD40L is expressed as a homotrimer on plasma membrane 2, 36 , and it was shown that clustering of membrane-bound CD40L molecules is necessary for CD40-medicated B cell activation 37 . However, the 18 kDa soluble form of CD40L also naturally arises from proteolytic processing as well, all of monomeric, dimeric and trimeric forms of soluble CD40L bind to CD40 molecules on the B cell membrane and activate the B cells at a certain level. 4, 38 Our system of modifying microbeads with CD40L in a defined and controllable molecular density, mimicking T H cells, is a rational approach to controlling the quality and quantity of CD40- Above, the same rationale was applied to account for the selective increase in antigen specific populations after sGC reactions in the presence of antigen even without the FACS enrichment step. The FACS enrichment step prior to the sGC culture simply made the selective increase in higher affinity B cells more visible. In this scenario, the presence of tetrameric epitope was essential to induce BCR-antigen affinity-dependent survival/proliferation signaling. Second, the increase in BCR affinity toward the antigen could also be introduced to the antigen-specific B cell populations as a result of somatic hypermutation (SHM) of the immunoglobulin (Ig) genes. In the GC, affinity maturation of the antibody responses is enabled by SHM of the variable regions of immunoglobulin genes 48, 49 and subsequent selection of higher-affinity B cell clones 50 . Similarly to CSR, SHM is known to be driven by AID (AICDA), which is largely expressed in GC B cells [15] [16] [17] .
As previously described, RT-PCR analysis confirmed that AICDA mRNA expression is highly upregulated in our sGC culture, even higher than in the natural GC B cells. In addition, it was previously reported that SHM can be induced in vitro when the surface BCRs are cross-linked in the presence of help from cognate T cells 51, 52 . agarose gels, which clearly showed DNA bands corresponding to heavy chain genes with IgGs and IgM isotype. The DNA were purified from the cutout bands using Gel Extraction Kit (Qiagen).
The next-generation sequencing was performed using 454 Sequencing System (Roche). All analyses for the resulting sequences were performed using IMGT/highV-Quest. The sequences showing V region identity of less than 90%, fewer than 200 base pairs, or unproductive protein translations were excluded from the analyses. Immunofluorescence microscopy. The inguinal lymph nodes harvested from the recipient mice embedded in O.C.T. compound (Sakura) were frozen in liquid nitrogen and kept at -80 o C. Frozen sections (7 μm thick) were fixed in cold acetone for 1 min. After washing 3 times with PBS, the sections were incubated with a blocking buffer (eBioscience) for 2 hours at room temperature.
The sections were stained with 5 μg ml-1 anti-CD4-eFluor570 (eBioscience) and anti-CD45R-APC (eBioscience) in TBS with 1% BSA for 4 hours at 4 o C. After 3 times of rinsing with 5 minute gentle agitation in TBS containing 0.025% Triton-X and 3 times of final washing with TBS, the sections were mounted with ProLong Gold antifade medium (Molecular Probes). All the samples were examined using Zeiss LSM 700 confocal microscope (Zeiss).
Statistical Analysis. The Student's t-test was performed for verification of statistical significance.
For multiple group comparison, ordinary one-way ANOVA analyses followed by Tukey's test were performed using GraphPad Prism software.
